Resilience

Resilience is a North American-based biomanufacturing CDMO offering end-to-end drug substance and drug product manufacturing for complex medicines, including biologics, vaccines, gene and cell therapies, and nucleic acids. The company emphasizes scalable, safe manufacturing and supply chain resilience, with facilities across the United States and Canada and global regulatory reach. Its offerings include biologics development, cell and gene therapy manufacturing, and platform-driven solutions designed to accelerate time-to-market from concept to commercialization. Resilience positions itself as a partner to small and mid-sized biotechs, providing flexible capacity and rapid tech transfer, scale-up, and release testing capabilities.